INMB INmune Bio Corporation: Net earnings per share for the last 12 months

Public company logo of INmune Bio Inc (INMB)

This price chart for INmune Bio, Inc. (INMB) reflects EPS dynamics currently standing at 71.10. Positive results from Phase 2 trials of the XPro drug for Alzheimer's and potential merger deals are driving the share price growth. The business relies on a universal immune-restoration technology applicable to both oncology and dementia. However, risks remain high due to a lack of sales and the early stages of product development.

INMB INmune Bio Inc Earnings per share for the last twelve months (02/11/2024 - 11/15/2026)

inmunebio.com - analytical breakdowns and key metrics (INMB)

- market value and analyst target forecast:
Stock Quotes INmune Bio Inc|INMB - Price Target Chart
- company stock capitalization data:
Market Valuation INmune Bio|INMB - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share INmune Bio|INMB - Company Book Value|Capitalization to Book Value Ratio inmunebio.com|INMB - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital INmune Bio, Inc.|INMB - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient inmunebio.com|INMB - Company Debts|Debt to Book Value Ratio INmune Bio Corporation|INMB - Company Long-Term Debt|Company Current Liabilities INmune Bio|Quick Ratio inmunebio.com
- earnings and multiples data:
INMB - Company Net Income|Net Profit Forecast INmune Bio, Inc.|INMB - P/E Multiple|Projected Price to Earnings Ratio INmune Bio, Inc.|INMB - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation INmune Bio Corp|INMB - Operating profit EBITDA|Earnings per share for the last twelve months INmune Bio|INMB - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months inmunebio.com|INMB - Earnings per share growth in current year|Expected net earnings per share growth next year INmune Bio, Inc.
- revenue and sales details:
INMB - Company Sales|Company Future Revenue INmune Bio|INMB - P/S Multiple|Market Cap to Expected Sales Ratio INmune Bio Corporation|INMB - Sales Growth YoY (Last Twelve Months)
Initial company analysis:INmune Bio Inc, INMB
Core merchandise of INmune Bio, Inc.

The twelve-month trailing earnings per share (EPS TTM) dynamics assess the operational efficiency and the business's ability to generate real income relative to capital. For INmune Bio, Inc. (INMB), whose valuation depends on the success of its Alzheimer's disease therapy, the current state of annual EPS TTM growth reflects the company's financial resilience during a period of costly clinical trials and immune response reprogramming.

Competitor analysis

argenx N.V. (ARGX) - Net earnings per share for the last 12 months|BioNTech Pharma (BNTX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Abivax|Net earnings per share for the last 12 months ADMA|Net earnings per share (EPS TTM) protagonist-inc.com|Earnings per share for the last twelve months Immunovant Corp (IMVT)|Kiniksa - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) GRFS (grifols.com)|Adaptive Biotechnologies Corp (ADPT) - Net earnings per one share for the last twelve months|celldex.com - Net earnings per share (EPS TTM)|AUPH - Net earnings per share (EPS TTM)|BCRX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Vera Therapeutics Inc (VERA)|DNTH (Dianthus Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Pharvaris Pharma|Net earnings per share (EPS TTM) ABCL|TRML (tourmalinebio.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PGEN (Precigen Inc)|PHAR - Net earnings per share for the last 12 months|NKTR - Earnings per share for the last twelve months|UPB - Net earnings per share (EPS TTM)|ZBIO: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Immunome, Inc.|Earnings per share for the last twelve months Gossamer Bio|Net earnings per share (EPS TTM) KalVista Pharmaceuticals Inc|Net earnings per share for the last 12 months SEPN (Septerna Corp)|PVLA (Pieris Pharmaceuticals Inc) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) SVRA (savarapharma.com)|Earnings per share for the trailing year RIGL|ANAB: Net earnings per share for the last 12 months|Earnings per share for the trailing year ATXS (Astria Therapeutics, Inc.)|ENGN: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months RAPT Therapeutics, Inc. (RAPT)|Earnings per share for the last twelve months aerovatetx.com|Net earnings per share (EPS TTM) aclaristx.com|Earnings per share for the last twelve months Kyverna Therapeutics (KYTX)|Net earnings per share for the last four quarters Tiziana Life Sciences Ltd|Net earnings per share (EPS TTM) CABA (Cabaletta Bio Inc)|VTYX: Earnings per share for the last 12 months|Theratechnologies, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Avalo Therapeutics, Inc AVTX|ELDN (Eledon Pharmaceuticals) - Net earnings per share for the last 12 months|Agenus Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Climb Bio|Net earnings per share (EPS TTM) Zura Bio Ltd|Net earnings per share for the last 12 months ATYR (aTyr Pharma Inc)|Net earnings per share for the last four quarters Adagene Inc|Earnings per share for the last twelve months ImageneBio Inc IMA|Earnings per share for the last four quarters STTK (shattucklabs.com)|EQ: Net earnings per share for the last 12 months|CNTB: Earnings per share for the last twelve months|IMUX: Net earnings per share (EPS TTM)|Atara Biotherapeutics (ATRA) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months IFRX|Net earnings per share (EPS TTM) X4 Pharmaceuticals Inc.|Earnings per share for the last twelve months Adicet Bio Inc. (ACET)|Net earnings per share for the last 12 months Celularity CELU|Earnings per share for the last twelve months barinthusbio.com BRNS|Earnings per share for the trailing year KZR|sabbiotherapeutics.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year AKTX (Akari Therapeutics PLC)|ENLV: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months QTTB|GOVX (geovax.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Edesa Biotech|Net earnings per share (EPS TTM) IBIO|Net earnings per share for the last 12 months Carisma Therapeutics Inc. CARM|Earnings per share for the last twelve months XTL Biopharmaceuticals, Ltd. XTLB|Net earnings per share (EPS TTM) boltbio.com BOLT|HCWB - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Aptevo Therapeutics Inc. APVO|AIM ImmunoTech, Inc. (AIM) - Earnings per share for the last twelve months|ADTX: Earnings per share for the last four quarters|GRI (GRI Bio Corporation) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) XORTX Therapeutics Inc.|Earnings per share for the last twelve months Vyome Holdings (HIND)|Net earnings per share for the last four quarters revbiosciences.com|Earnings per share for the last twelve months Indaptus Therapeutics Inc INDP|Net earnings per share (EPS TTM) Scinai SCNI|CALI - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AFMD|ALLK (Allakos Therapeutics) - Net earnings per share for the last 12 months|HOOKIPA - Earnings per share for the trailing year|IGMS (IGM Biosciences) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months iTeos Therapeutics Inc ITOS|Earnings per share for the last twelve months oceanbiomedical.com (OCEA)|Net earnings per share for the last 12 months TC Biopharm TCBP|Net earnings per share (EPS TTM) THRD (Third Harmonic Bio, Inc.)